[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]
Maria Tablado MA.
europepmc +1 more source
SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population. [PDF]
Kulisevsky J +6 more
europepmc +1 more source
[Detection of antibodies against SARS-CoV-2 in CHUAC emergency staff after the administration of the Comirnaty vaccine (Pfizer-BioNTech): a retrospective study]. [PDF]
Rodríguez Buyo IM +3 more
europepmc +1 more source
[Continuous Subcutaneous Apomorphine Infusion Therapy: Economic Impact in Spain]. [PDF]
Micolta-Córdoba L +2 more
europepmc +1 more source
Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America. [PDF]
Pérez-Salazar K +2 more
europepmc +1 more source
Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]
Caffaratti M +9 more
europepmc +1 more source
[Arthritis secondary to tirzepatide. Case report]. [PDF]
Martín Correa E +2 more
europepmc +1 more source
No se conoce si el factor de transferencia provoca reacciones adversas, ni cómo se prescribe en las condiciones de la práctica médica habitual. Objetivos. Identificar reacciones adversas del factor de transferencia y caracterizar su prescripción.
core
[Adverse drug reactions and letters to the editor]. [PDF]
Garcia Llopis P +2 more
europepmc +1 more source
Knowledge, attitudes, and practices regarding self-medication among Generation Z university students. [PDF]
Silveira HNG +7 more
europepmc +1 more source

